{"schema_version":"secwatch.filing_event.v1","accession":"0001477932-26-005750","form_type":"8-K","ticker":"CTTH","cik":"0001035422","company_name":"CTT PHARMACEUTICAL HOLDINGS, INC.","filed_at":"2026-09-22T22:25:42+00:00","discovered_at":"2026-09-23T10:05:06.649382+00:00","generated_at":"2026-09-23T10:06:17.685324+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"CTT Pharmaceuticals adds Karen Larson as Independent Board Member","bullets":["Karen Larson appointed Independent Board Member of CTT Pharmaceutical Holdings, Inc. (OTCQB:CTTH).","Larson is a Certified Financial Planner; her analytical reporting business was sold to Morningstar.","Previously Senior Vice President, Investment Banker at Chase Manhattan Bank.","Since 2017, founding member of Broad Avenue Studios, Inc., a commercial and residential real estate company."],"urls":{"canonical":"https://secwatch.observer/filing/0001477932-26-005750","json":"https://secwatch.observer/filing/0001477932-26-005750.json","markdown":"https://secwatch.observer/filing/0001477932-26-005750.md","text":"https://secwatch.observer/filing/0001477932-26-005750.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1035422/000147793226005750/0001477932-26-005750-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1035422/000147793226005750/ctth_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-09-23T10:06:17.685324+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}